{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:42:54Z","timestamp":1790077374190,"version":"4.0.1"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01-DA036297"],"award-info":[{"award-number":["U01-DA036297"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-DA057673"],"award-info":[{"award-number":["R01-DA057673"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence Reports"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.dadr.2025.100403","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T16:20:19Z","timestamp":1765038019000},"page":"100403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Characterizing patterns of opioid and stimulant use by route and associations with non-fatal overdose and xylazine use in people who have injected drugs from Baltimore, MD, 2023\u20132024"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7177-1847","authenticated-orcid":false,"given":"Jacqueline E.","family":"Rudolph","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2073-3418","authenticated-orcid":false,"given":"Liz M.","family":"Martinez-Ocasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9003-3081","authenticated-orcid":false,"given":"Kenneth A.","family":"Feder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Tomko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0304-3172","authenticated-orcid":false,"given":"Javier A.","family":"Cepeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory D.","family":"Kirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2523-0959","authenticated-orcid":false,"given":"Shruti H.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9604-5817","authenticated-orcid":false,"given":"Danielle","family":"German","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Becky L.","family":"Genberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dadr.2025.100403_bib1","unstructured":"Abuse, N.I. On D., 2024. Drug Overdose Deaths: Facts and Figures | National Institute on Drug Abuse (NIDA) [WWW Document]. URL \u3008https:\/\/nida.nih.gov\/research-topics\/trends-statistics\/overdose-death-rates\u3009 (accessed 7.17.25)."},{"key":"10.1016\/j.dadr.2025.100403_bib2","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/add.13339","article-title":"Differences in polysubstance use patterns and drug-related outcomes between people who inject drugs receiving and not receiving opioid substitution therapies","volume":"111","author":"Betts","year":"2016","journal-title":"Addict. Abingdon Engl."},{"key":"10.1016\/j.dadr.2025.100403_bib3","first-page":"47","article-title":"Patterns and motivations of polysubstance use: a rapid review of the qualitative evidence","volume":"42","author":"Boileau-Falardeau","year":"2022","journal-title":"Health Promot. Chronic Dis. Prev. Can. Res. Policy Pr."},{"key":"10.1016\/j.dadr.2025.100403_bib4","doi-asserted-by":"crossref","DOI":"10.1186\/s12954-024-00959-2","article-title":"Xylazine co-occurrence with illicit fentanyl is a growing threat in the Deep South: a retrospective study of decedent data","volume":"21","author":"Bradford","year":"2024","journal-title":"Harm. Reduct. J."},{"key":"10.1016\/j.dadr.2025.100403_bib5","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.50630","article-title":"Xylazine in overdose deaths and forensic drug reports in US States, 2019-2022","volume":"7","author":"Cano","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.dadr.2025.100403_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213357","article-title":"Rising role of prescription drugs as a portal to injection drug use and associated mortality in Baltimore, Maryland","volume":"14","author":"Cepeda","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.dadr.2025.100403_bib7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugpo.2017.06.010","article-title":"Fentanyl in the US heroin supply: a rapidly changing risk environment","volume":"46","author":"Ciccarone","year":"2017","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.dadr.2025.100403_bib8","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","article-title":"The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis","volume":"34","author":"Ciccarone","year":"2021","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.dadr.2025.100403_bib9","doi-asserted-by":"crossref","first-page":"244","DOI":"10.2105\/AJPH.2019.305412","article-title":"Polysubstance use: a broader understanding of substance use during the opioid crisis","volume":"110","author":"Cicero","year":"2020","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.dadr.2025.100403_bib10","series-title":"Mass overdose in Baltimore may be tied to new illicit drug mixed with fentanyl","author":"Cohn","year":"2025"},{"key":"10.1016\/j.dadr.2025.100403_bib11","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.drugpo.2019.07.030","article-title":"The prevalence of non-fatal overdose among people who inject drugs: a multi-stage systematic review and meta-analysis","volume":"73","author":"Colledge","year":"2019","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.dadr.2025.100403_bib12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41380-020-00949-3","article-title":"Polysubstance use in the U.S. opioid crisis","volume":"26","author":"Compton","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.dadr.2025.100403_bib13","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3389\/fnins.2020.00569","article-title":"One is not enough: understanding and modeling polysubstance use","volume":"14","author":"Crummy","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.dadr.2025.100403_bib14","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.7326\/M23-2001","article-title":"Xylazine adulteration of the heroin-fentanyl drug supply: a narrative review","volume":"176","author":"D\u2019Orazio","year":"2023","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.dadr.2025.100403_bib15","first-page":"189","article-title":"Heroin overdose: research and evidence-based intervention","volume":"80","author":"Darke","year":"2003","journal-title":"J. Urban Health Bull. N. Y. Acad. Med."},{"key":"10.1016\/j.dadr.2025.100403_bib16","doi-asserted-by":"crossref","DOI":"10.2202\/1544-6115.1309","article-title":"Super learner","volume":"6","author":"van der Laan","year":"2007","journal-title":"Stat. Appl. Genet Mol. Biol."},{"key":"10.1016\/j.dadr.2025.100403_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108228","article-title":"Polysubstance use among youth experiencing homelessness: the role of trauma, mental health, and social network composition","volume":"216","author":"DiGuiseppi","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2025.100403_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.110954","article-title":"Trends in self-reported non-fatal overdose and patterns of substance use before and during the COVID-19 pandemic in a prospective cohort of adults who have injected drugs - Baltimore, Maryland, 2014-2022","volume":"251","author":"Feder","year":"2023","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2025.100403_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109380","article-title":"Xylazine spreads across the US: a growing component of the increasingly synthetic and polysubstance overdose crisis","volume":"233","author":"Friedman","year":"2022","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2025.100403_bib20","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1111\/add.16318","article-title":"Charting the fourth wave: geographic, temporal, race\/ethnicity and demographic trends in polysubstance fentanyl overdose deaths in the United States, 2010-2021","volume":"118","author":"Friedman","year":"2023","journal-title":"Addict. Abingdon Engl."},{"key":"10.1016\/j.dadr.2025.100403_bib21","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/aje\/kwq441","article-title":"Trajectories of injection drug use over 20 years (1988-2008) in Baltimore, Maryland","volume":"173","author":"Genberg","year":"2011","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.dadr.2025.100403_bib22","doi-asserted-by":"crossref","DOI":"10.1186\/s12954-024-00940-z","article-title":"Reported xylazine exposure highly associated with overdose outcomes in a rapid community assessment among people who inject drugs in Baltimore","volume":"21","author":"German","year":"2024","journal-title":"Harm. Reduct. J."},{"key":"10.1016\/j.dadr.2025.100403_bib23","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1521\/aeap.2019.31.4.344","article-title":"Association of injection practices and overdose with drug use typologies: a latent class analysis among people who inject drugs in Baltimore, 2017","volume":"31","author":"Gicquelais","year":"2019","journal-title":"AIDS Educ. Prev. Off. Publ. Int. Soc. AIDS Educ."},{"key":"10.1016\/j.dadr.2025.100403_bib24","first-page":"180","article-title":"Characterization of nonfatal opioid, cocaine, methamphetamine, and polydrug exposure and clinical presentations reported to the toxicology investigators consortium core registry, January 2010-December 2021","volume":"19","author":"Glidden","year":"2023","journal-title":"J. Med. Toxicol. Off. J. Am. Coll. Med. Toxicol."},{"key":"10.1016\/j.dadr.2025.100403_bib25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/ADM.0000000000001383","article-title":"Personal experiences with xylazine and behavior change: a qualitative content analysis of reddit posts","volume":"19","author":"Heidari","year":"2025","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.dadr.2025.100403_bib26","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.0572","article-title":"Knowledge, preference, and adverse effects of xylazine among adults in substance use treatment","volume":"7","author":"Hochheimer","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.dadr.2025.100403_bib27","first-page":"395","article-title":"Increasing presence of xylazine in heroin and\/or fentanyl deaths, Philadelphia, Pennsylvania, 2010-2019","volume":"27","author":"Johnson","year":"2021","journal-title":"InJ. Prev. J. Int. Soc. Child Adolesc. InJ. Prev."},{"key":"10.1016\/j.dadr.2025.100403_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103584","article-title":"Latent patterns of polysubstance use among people who use opioids: a systematic review","volume":"102","author":"Karamouzian","year":"2022","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.dadr.2025.100403_bib29","doi-asserted-by":"crossref","first-page":"721","DOI":"10.15585\/mmwr.mm7226a4","article-title":"Illicitly manufactured fentanyl-involved overdose deaths with detected xylazine - United States, January 2019-June 2022","volume":"72","author":"Kariisa","year":"2023","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.dadr.2025.100403_bib30","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1111\/dar.14093","article-title":"Fentanyl polysubstance use patterns and their associations With Hepatitis C virus, skin and soft tissue infections, and non-fatal overdose among people who inject drugs in New York City","volume":"44","author":"Khezri","year":"2025","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.dadr.2025.100403_bib31","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3109\/10826084.2015.1122063","article-title":"Comparisons of Cocaine-only, opioid-only, and users of both substances in the national epidemiologic survey on alcohol and related conditions (NESARC)","volume":"51","author":"Leeman","year":"2016","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.dadr.2025.100403_bib32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1360-0443.2003.00236.x","article-title":"Understanding polydrug use: review of heroin and cocaine co-use","volume":"98","author":"Leri","year":"2003","journal-title":"Addict. Abingdon Engl."},{"key":"10.1016\/j.dadr.2025.100403_bib33","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/ADM.0000000000001319","article-title":"Coke in the dope: the underrecognized complications of a cocaine-adulterated fentanyl supply","volume":"18","author":"Mariano","year":"2024","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.dadr.2025.100403_bib34","unstructured":"Maryland Department of Health, 2025. Unintentional Drug and Alcohol-Related Intoxication Deaths. (accessed 7.17.23).https:\/\/health.maryland.gov\/vsa\/Pages\/overdose.aspx."},{"key":"10.1016\/j.dadr.2025.100403_bib35","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2471\/BLT.12.108282","article-title":"Mortality among people who inject drugs: a systematic review and meta-analysis","volume":"91","author":"Mathers","year":"2013","journal-title":"Bull. World Health Organ"},{"key":"10.1016\/j.dadr.2025.100403_bib36","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2105\/AJPH.2016.303627","article-title":"Recent increases in cocaine-related overdose deaths and the role of opioids","volume":"107","author":"McCall Jones","year":"2017","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.dadr.2025.100403_bib37","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13033-023-00601-x","article-title":"Shifting drug markets in North America - a global crisis in the making?","volume":"17","author":"Meyer","year":"2023","journal-title":"Int. J. Ment. Health Syst."},{"key":"10.1016\/j.dadr.2025.100403_bib38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/PAF.0000000000000622","article-title":"Xylazine, a veterinary tranquilizer, detected in 42 accidental fentanyl intoxication deaths","volume":"42","author":"Nunez","year":"2021","journal-title":"Am. J. Forensic Med. Pathol."},{"key":"10.1016\/j.dadr.2025.100403_bib39","unstructured":"Maryland Department of Health, 2025MDH Interactive Dashboards https:\/\/health.maryland.gov\/dataoffice\/Pages\/mdh-dashboards.aspx(accessed 7.17.25).."},{"key":"10.1016\/j.dadr.2025.100403_bib40","article-title":"Trends in HIV and HCV prevention efforts and incidence among people who inject drugs in Baltimore","author":"Patel","year":"2024","journal-title":"Presente Conf. Retrovir. Opportunistic Infect. Denver CO"},{"key":"10.1016\/j.dadr.2025.100403_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2023.104154","article-title":"Xylazine in the drug supply: emerging threats and lessons learned in areas with high levels of adulteration","volume":"120","author":"Quijano","year":"2023","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.dadr.2025.100403_bib42","article-title":"Perspectives of people in Philadelphia who use fentanyl\/heroin adulterated with the animal tranquilizer xylazine; making a case for xylazine test strips","volume":"4","author":"Reed","year":"2022","journal-title":"Drug Alcohol Depend. Rep."},{"key":"10.1016\/j.dadr.2025.100403_bib43","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s11524-011-9662-6","article-title":"The emerging of xylazine as a new drug of abuse and its health consequences among drug users in Puerto Rico","volume":"89","author":"Reyes","year":"2012","journal-title":"J. Urban Health"},{"key":"10.1016\/j.dadr.2025.100403_bib44","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2105\/AJPH.2024.307979","article-title":"Polysubstance use profiles among the general adult population, United States, 2022","volume":"115","author":"Rockhill","year":"2025","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.dadr.2025.100403_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2024.104364","article-title":"Longitudinal patterns of use of stimulants and opioids in the AIDS linked to the IntraVenous experience cohort, 2005-2019","volume":"126","author":"Rudolph","year":"2024","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.dadr.2025.100403_bib46","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12874-018-0605-8","article-title":"Parametric assumptions equate to hidden observations: comparing the efficiency of nonparametric and parametric models for estimating time to AIDS or death in a cohort of HIV-positive women","volume":"18","author":"Rudolph","year":"2018","journal-title":"BMC Med. Res. Method."},{"key":"10.1016\/j.dadr.2025.100403_bib47","doi-asserted-by":"crossref","first-page":"458","DOI":"10.15585\/mmwr.mm7217a2","article-title":"Rapid analysis of drugs: a pilot surveillance system to detect changes in the illicit drug supply to guide timely harm reduction responses \u2014 eight syringe services programs, Maryland, November 2021\u2013August 2022","volume":"72","author":"Russell","year":"2023","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.dadr.2025.100403_bib48","unstructured":"San Francisco Chronicle, 2025. Drug overdose deaths: Tracking devastating toll of U.S. crisis [WWW Document]. San Franc. Chron. URL \u3008https:\/\/www.sfchronicle.com\/projects\/us-drug-overdose-deaths\/\u3009 (accessed 7.17.25)."},{"key":"10.1016\/j.dadr.2025.100403_bib49","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.drugalcdep.2019.03.026","article-title":"Patterns of polysubstance use and overdose among people who inject drugs in Baltimore, Maryland: a latent class analysis","volume":"201","author":"Schneider","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2025.100403_bib50","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.drugalcdep.2005.11.007","article-title":"Longitudinal predictors of injection cessation and subsequent relapse among a cohort of injection drug users in Baltimore, MD, 1988-2000","volume":"83","author":"Shah","year":"2006","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2025.100403_bib51","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/29767342241265181","article-title":"Exploring xylazine awareness, health impacts, and harm reduction strategies: findings from a multimethods study in Lowell, Massachusetts","volume":"46","author":"Shrestha","year":"2025","journal-title":"Subst. Use Addict. J."},{"key":"10.1016\/j.dadr.2025.100403_bib52","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/ADM.0000000000001107","article-title":"Injection of methamphetamine has increased in Boston, Massachusetts: 5 waves of centers for disease control and prevention state surveillance data","volume":"17","author":"Streck","year":"2023","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.dadr.2025.100403_bib53","doi-asserted-by":"crossref","first-page":"799","DOI":"10.15288\/jsad.2018.79.799","article-title":"Polysubstance use by stimulant users: health outcomes over three years","volume":"79","author":"Timko","year":"2018","journal-title":"J. Stud. Alcohol Drugs"},{"key":"10.1016\/j.dadr.2025.100403_bib54","article-title":"Xylazine (veterinary sedative) use in Puerto Rico","volume":"6","author":"Torruella","year":"2011","journal-title":"Subst. Abus. Treat. Prev. Policy"},{"key":"10.1016\/j.dadr.2025.100403_bib55","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/aje\/kwab290","article-title":"Racial\/ethnic and geographic trends in combined stimulant\/opioid overdoses, 2007-2019","volume":"191","author":"Townsend","year":"2022","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.dadr.2025.100403_bib56","unstructured":"U.S. Department of Justice Drug Enforcement Administration, 2022. The growing threat of xylazine and its mixture with illicit drugs (No. DEA-DCI-DIR-001-23). U.S. Department of Justice."},{"key":"10.1016\/j.dadr.2025.100403_bib57","doi-asserted-by":"crossref","DOI":"10.2202\/1557-4679.1043","article-title":"Targeted maximum likelihood learning","volume":"2","author":"Van Der Laan","year":"2006","journal-title":"Int. J. Biostat."},{"key":"10.1016\/j.dadr.2025.100403_bib58","first-page":"75","article-title":"The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants","volume":"109","author":"Vlahov","year":"1991","journal-title":"NIDA Res Monogr."},{"key":"10.1016\/j.dadr.2025.100403_bib59","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1080\/15563650.2023.2288540","article-title":"Qualitative and quantitative characteristics of xylazine-associated deaths detected using a post-mortem toxicology testing program","volume":"61","author":"Vohra","year":"2023","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.dadr.2025.100403_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.110985","article-title":"Prevalence of fentanyl in methamphetamine and cocaine samples collected by community-based drug checking services","volume":"252","author":"Wagner","year":"2023","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2025.100403_bib61","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/ADM.0000000000000695","article-title":"Rise in presence of methamphetamine in oral fluid toxicology tests among outpatients in a large healthcare setting in the Northeast","volume":"15","author":"Wakeman","year":"2021","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.dadr.2025.100403_bib62","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1353\/obs.2023.0019","article-title":"lmtp: an R package for estimating the causal effects of modified treatment policies","volume":"9","author":"Williams","year":"2023","journal-title":"Obs. Stud."}],"container-title":["Drug and Alcohol Dependence Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724625000861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724625000861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T08:35:17Z","timestamp":1773909317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772724625000861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":62,"alternative-id":["S2772724625000861"],"URL":"https:\/\/doi.org\/10.1016\/j.dadr.2025.100403","relation":{},"ISSN":["2772-7246"],"issn-type":[{"value":"2772-7246","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterizing patterns of opioid and stimulant use by route and associations with non-fatal overdose and xylazine use in people who have injected drugs from Baltimore, MD, 2023\u20132024","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dadr.2025.100403","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100403"}}